United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded May 19, 2026 · Filed May 20, 2026

On May 19, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$567.94 for US$5.4M under a trading plan, leaving 40,513 shares. Filed May 20, 2026 (Form 4).

Sold
9,500 shares
Price
US$567.94 average (US$561.52 to US$572.36)
Value
US$5.4M
Holding after
40,513 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 19, 2026Common StockOption exercise9,500US$146.0350,013Direct
May 19, 2026Common StockSale51US$561.5249,962Direct
May 19, 2026Common StockSale109US$562.3149,853Direct
May 19, 2026Common StockSale1,237US$565.5448,616Direct
May 19, 2026Common StockSale2,140US$566.3446,476Direct
May 19, 2026Common StockSale1,149US$567.3845,327Direct
May 19, 2026Common StockSale1,640US$568.4643,687Direct
May 19, 2026Common StockSale1,393US$569.4242,294Direct
May 19, 2026Common StockSale1,099US$570.3541,195Direct
May 19, 2026Common StockSale562US$571.2440,633Direct
May 19, 2026Common StockSale120US$572.3640,513Direct

Source

View original at SEC

Related